Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$892.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Jan 2 | DRMA | Dermata Therapeutics, Inc. | AGRANT◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 21, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 21, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL◷ | 12,500 | $15.00 | $187.5K | -55.5% | Open the original filing on SEC.gov |
| Aug 21, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◷ | 12,500 | $1.50 | $18.8K | +124.5% | Open the original filing on SEC.gov |
| May 20, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| May 20, 2025 | SPRY | ARS Pharmaceuticals, Inc. | SSELL | 50,000 | $14.10 | $705.2K | -87.1% | Open the original filing on SEC.gov |
| May 20, 2025 | SPRY | ARS Pharmaceuticals, Inc. | MEXER | 50,000 | $1.50 | $75K | +673.5% | Open the original filing on SEC.gov |